MEDIUM confidence: 100% data completeness, but the composite (53) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $276.1B— | $302.0B+9.4% | $364.5B+20.7% | $371.4B+1.9% | $371.4B+0.0% |
| EPS (dil.) | $39.64— | $-10.36-126.1% | $44.27n/m | $41.27-6.8% | $31.04-24.8% |
| Free Cash Flow | $26.1B— | $21.8B-16.8% | $29.8B+36.9% | $11.6B-61.0% | $25.0B+115.6% |
| Gross Margin | 20.0% | 19.7%-0.3pp | 19.5%-0.2pp | 23.3%+3.8pp | 23.6%+0.3pp |
| Operating Margin | 12.7% | 13.8%+1.1pp | 13.2%-0.6pp | 16.0%+2.8pp | 15.9%-0.2pp |
| Net Margin | 32.6% | -7.5%-40.1pp | 26.4%+33.9pp | 24.0%-2.4pp | 18.0%-5.9pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
No recent open-market insider transactions.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Buy-rated share 75% → 50% over ~3 months (-25pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Aug 2026 | $5.04 | $6.02 | +19.4% |
| May 2026 | $5.08 | $5.25 | +3.3% |
| Mar 2026 | $5.51 | $4.73 | -14.2% |
| Nov 2025 | $5.39 | $14.27 | +164.7% |
| Aug 2025 | $5.04 | $5.73 | +13.7% |
| May 2025 | $4.63 | $4.47 | -3.5% |
| Feb 2025 | $4.22 | $6.73 | +59.5% |
| Nov 2024 | $4.51 | $4.68 | +3.8% |
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of -0.3%/yr (revenue basis).
Base free cash flow $22.1B (avg FY2023–FY2025; latest year $25.0B) · equity value $1.10T · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
The QScore of 53 for BRK-B suggests a neutral outlook, driven by its strong momentum and value scores, which are offset by weaker growth and profitability metrics. The stock exhibits strong momentum, with a 12-month return of 9.7% and a bullish 50-day versus 200-day moving average trend. In contrast, its growth score is hindered by a decline in EPS growth of 24.8%, while its profitability score is weighed down by a relatively modest ROE of 11.9%. The long-term and short-term scores are relatively aligned, with only a 4-point difference.